DRUG-DRUG INTERACTIONS WITH THE USE OF PSYCHOTROPIC MEDICATIONS

[1] CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: Intraindividual variability and plasma concentration correlations [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01) : 58 - 66

[2] CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (02) : 155 - 163

[3] Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (04) : 443 - 451

[4] The use of BDDCS in classifying the permeability of marketed drugs [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (03) : 483 - 488

[5] The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions [J]. CURRENT DRUG TARGETS, 2004, 5 (06) : 573 - 579

[6] Dextromethorphan-induced manic symptoms in a bipolar patient on lithium [J]. PSYCHOSOMATICS, 1996, 37 (06) : 571 - 572

[7] Chavez M. L., 2005, INETCE, V9, P1

[8] Chong SA, 2001, ANN ACAD MED SINGAP, V30, P625

[9] Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter? [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (03) : 217 - 223

[10] CLOVIS WL, 1993, J CLIN PSYCHIAT, V54, P200

[1] CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: Intraindividual variability and plasma concentration correlations [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01) : 58 - 66

[2] CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (02) : 155 - 163

[3] Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (04) : 443 - 451

[4] The use of BDDCS in classifying the permeability of marketed drugs [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (03) : 483 - 488

[5] The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions [J]. CURRENT DRUG TARGETS, 2004, 5 (06) : 573 - 579

[6] Dextromethorphan-induced manic symptoms in a bipolar patient on lithium [J]. PSYCHOSOMATICS, 1996, 37 (06) : 571 - 572

[7] Chavez M. L., 2005, INETCE, V9, P1

[8] Chong SA, 2001, ANN ACAD MED SINGAP, V30, P625

[9] Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter? [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (03) : 217 - 223

[10] CLOVIS WL, 1993, J CLIN PSYCHIAT, V54, P200